Developments in treatment for parkinson's disease

Developments in treatment for parkinson's disease

Detalhes bibliográficos
Autor principal:	Cotzias, George C., ed.McDowell, Fletcher H., ed
Formato:	Livro
Idioma:	Spanish
Assuntos:	Dopa-Therapeutic use Parkinsonism-Drug therapy

Registros relacionados

Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C
por: Gavier, B. (B.), et al.
Publicado em: (2012)

Treatment of Dysphagia in Parkinson’s Disease: A Systematic Review
por: López Liria, Remedios, et al.
Publicado em: (2020)

Structural features governing the activity of lactoferricin-derived peptides that act in synergy with antibiotics against Pseudomonas aeruginosa in vitro and in vivo
por: Sánchez-Gómez, S. (Susana), et al.
Publicado em: (2013)

Farmacología de antimicrobianos utilizados en el tratamiento de las infecciones graves por bacterias grampositivas
por: Garcia-Quetglas, E. (Emilio), et al.
Publicado em: (2013)

Music Therapy and Parkinson’s Disease: A Systematic Review from 2015-2020
por: Machado Sotomayor, Manuel Joaquín, et al.
Publicado em: (2021)

Efficacy of Specific Trunk Exercises in the Balance Dysfunction of Patients with Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: López Liria, Remedios, et al.
Publicado em: (2023)

Do the low molecular weight heparins improve efficacy and safety of the treatment of deep venous thrombosis? A meta-analysis
por: Rocha, E. (Eduardo), et al.
Publicado em: (2012)

Treatment of Vascular Parkinsonism: A Systematic Review
por: Toro-Pérez, Cristina del, et al.
Publicado em: (2023)

Glucocerebrosidase gene therapy in animal models of Parkinson Disease
por: Sucunza, D. (Diego), et al.
Publicado em: (2021)

Caracterización y variabilidad de los informes de evaluación de medicamentos en la página web del grupo GENESIS de la SEFH
por: Ortega-Eslava, A. (Ana), et al.
Publicado em: (2012)

Development of three-dimensional biomaterials containing stem cells and neurotrophic factors for brain repair in Parkinson's disease
por: Torres-Ortega, P.V. (Pablo Vicente), et al.
Publicado em: (2022)

La danza en el parkinson. Revisión sistemática
por: Ruiz Higueras, Teresa
Publicado em: (2021)

Potential therapeutic targets shared between leishmaniasis and cancer
por: Rashidi, S. (Sajad), et al.
Publicado em: (2021)

Potential therapeutic targets shared between leishmaniasis and cancer
por: Rashidi, S. (Sajad), et al.
Publicado em: (2022)

Cost-effectiveness analysis of tropisetron vs. chlorpromazine-dexamethasone in the control of acute emesis induced by highly emetogenic chemotherapy in children
por: Tejedor, I. (I.), et al.
Publicado em: (2012)

Anxiolytic and Antidepressant Use and Burnout: Optimism as a Mediator in Spanish Nurses
por: Martos Martínez, África, et al.
Publicado em: (2021)

World malaria report 2011

Enfermedad de parkinson y síndromes parkinsonianos

Effects of dexmedetomidine on subthalamic local field potentials in parkinson's disease
por: Martinez-Simon, A. (Antonio), et al.
Publicado em: (2022)

Cortical hypoperfusion in Parkinson's disease assessed using arterial spin labeled perfusion MRI
por: Fernández-Seara, M.A. (María A.), et al.
Publicado em: (2012)

Microfluidic platforms for the validation of new targeted therapies for personalised medicine against osteosarcoma.
por: Mitxelena-Iribarren, O. (Oihane), et al.
Publicado em: (2021)

Discovery and validation of Lmj_04_BRCT domain, a novel therapeutic target: identification of candidate drugs for leishmaniasis
por: Peña-Guerrero, J. (José), et al.
Publicado em: (2022)

rAAV8-mediated in vivo reprogramming of striatal astrocytes into neurons as a potential therapeutic strategy for neurodegenerative diseases
por: Pignataro, D. (Diego), et al.
Publicado em: (2018)

Parkinson: la ley
por: Parkinson, C. Northcote

Development of disease and drug models for rare diseases: Application to Acute Intermittent Porphyria.
por: Vera-Yunca, D. (Diego), et al.
Publicado em: (2022)

Frozen cancellous bone allografts: positive cultures of implanted grafts in posterior fusions of the spine
por: Barriga, A. (Andrés), et al.
Publicado em: (2012)

Relación entre estructura y función en los azoles
por: Sadaba, B. (Belén), et al.
Publicado em: (2013)

Impacto de polimorfismos genéticos de la vía metabólica del metotrexato sobre la sobrevida de niños mexicanos con leucemia linfoblástica aguda (LLA)
por: Zaruma Torres, Fausto Leonardo
Publicado em: (2018)

Estudio clínico de lovastatina frente a gemfibrozil en el tratamiento de la hipercolesterolemia primaria
por: Catalan, M. (M.), et al.
Publicado em: (2013)

Parkinson y pesticidas.
por: García Martínez, Cristina
Publicado em: (2012)

Non-Immersive Virtual Reality to Improve Balance and Reduce Risk of Falls in People Diagnosed with Parkinson’s Disease: A Systematic Review
por: García López, Hector, et al.
Publicado em: (2021)

A systematic review of drug allergy alert systems
por: Luri-Fernández-de-Manzanos, M. (Marta), et al.
Publicado em: (2022)

El Parkinson y los pesticidas
por: Fortes Asensio, Gema
Publicado em: (2013)

Mining Small Routine Clinical Data: A Population Pharmacokinetic Model and Optimal Sampling Times of Capecitabine and its Metabolites
por: Oyaga-Iriarte, E. (Esther), et al.
Publicado em: (2021)

Current Therapy: latest approved methods of treatment for the practicing physician
por: Conn, Howard F.

Current Therapy: latest approved methods of treatment for the practicing physician
por: Conn, Howard F.

La enfermedad de Parkinson: aspectos epidemiológicos, diagnósticos y terapéuticos /
Publicado em: (1985)

A Manual of clinical therapeutics
por: Cutting, Windsor C

Efficacy of Physiotherapy Treatment in Primary Dysmenorrhea: A Systematic Review and Meta-Analysis
por: López Liria, Remedios, et al.
Publicado em: (2021)

Construcción de un Índice que permita la evaluación integral de la Enfermedad de Parkinson (ÍNDICE DE GRAVEDAD DE LA ENFERMEDAD DE PARKINSON -IGEP-), mediante el empleo del Escalamiento Óptimo
por: Serrano-Dueñas, M. (Marcos), et al.
Publicado em: (2024)